The DOI matches its Crossref record.
Bleomycin: current Status and New Developments
Open accessAbstract
devoted to the characteristic radiological changes observed in the gastro-intestinal tract in association with primary and secondary immunodeficiences and with the lym-phoreticular neoplasias. Other excellent chapters are contributed by D Wright (Burkitt Lymphoma and Infectious Mononucleosis) and by R. A. Good and colleagues (Immunodeficiencies associated with the Leukaemias, Multiple Myeloma and Non-Hodgkin Lymphoma) to name but a few. In summary then this is a very substantial text for which a brief review can do little other than commend to those investigating in the field, what is a significant addition to the literature on the immunopathology of lym-phoreticular neoplasms. This is a comprehensive review of the current status of the biology, pharmacology and clinical status of bleomycin, and it is a comprehensive review of the present status of this relatively new chemotherapeutic agent. The biological reviews are written by experts in the field of bleomycin biochemistry and pharmacology and represent a succinct summary of advances to date. A comprehensive review of the morphological toxicity of bleomycin therapy is also presented in this early section. The latter part of the book deals with the clinical evaluation of bleomycin in a number of malignant diseases, and these are in general excellent reviews of the range of activity of bleomycin and its limitation in clinical practice. Important additional sections include the use of bleomycin, in combination with a number of other agents, including radio-therapy. The final part of this book concerns the search and development of new bleomycin derivatives with a major thrust is to develop agents that have less pulmonary toxicity than the current compound. This book can be strongly recommended for all practising oncologists. It is a substantial achievement to have so many authorities writing in a single volume, which overall represents a very balanced approach in the literature of this new and important agent. This book is primarily an account of electro-chemical methods for the investigation of the properties of cellular surfaces, and it covers this narrow field thoroughly and clearly. There are extensive discussions of the theoretical bases for the electrometic titration of cells, for cell electrophoresis and for iso-electric focusing, but perhaps in such detail as to deter most biologists. Equally, the physical chemist, seeking to apply his subject to a biological system, may feel that slightly more extensive theoretical discussion wNould be justified. The early chapters outline present theories of membrane structure and consider the nature and properties …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563
Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine
Rege, N. N., Thatte, U. M., & Dahanukar, S. A. (1999) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199906)13:4<275::aid-ptr510>3.0.co;2-s · Cited by 488
Carbon—Hydrogen Bonds of DNA Sugar Units as Targets for Chemical Nucleases and Drugs
Pratviel, G., Bernadou, J., & Meunier, B. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199507461 · Cited by 422
Molecular Mechanisms of Antisense Oligonucleotides
Crooke, S. T. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0656 · Cited by 396
Mechanisms of bleomycin-induced lung damage
Hay, J., Shahzeidi, S., & Laurent, G. (1991) · Archives of Toxicology · doi:10.1007/bf02034932 · Cited by 389
Metadata
- Authors
- Bush, H.
- Venue
- British Journal of Cancer
- Published
- 1979-08-01
- Volume
- 40
- Issue
- 2
- Pages
- 326-326
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2042423848
- Cited by
- 196
- References
- 0
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bleomycin: current Status and New Developments. https://app.cochat.ai/papers/10.1038/bjc.1979.184
- The paper
- Bush, H. (1979). Bleomycin: current Status and New Developments. British Journal of Cancer. https://doi.org/10.1038/bjc.1979.184
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.